Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

SPDR® S&P Biotech ETF (XBI)

BATS BZX Real-Time Price
As of 11:24am ET
 -1.29 / -1.90%
Today’s Change
Today|||52-Week Range

Investment Objective

The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the S&P Biotechnology Select Industry Index derived from the biotechnology segment of a U.S. total market composite index. In seeking to track the performance of the S&P Biotechnology Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the biotechnology segment of the S&P Total Market Index ("S&P TMI"). The fund is non-diversified.


1 month+7.28% 3 years+8.04%
3 months+4.86% 5 years+22.16%
1 year+34.17% Since inception+14.02%
Data through 02/23/2017

Quote Details

Previous close$67.79
Open day’s range66.26 – 67.91
Net asset value (NAV)67.75 (02/22/2017)
Daily volume147,908
Average volume (3 months)6,316,036
Data as of 11:24am ET, 02/23/2017

Peer Comparisonvs. Health ETFs

Performance 5-yr return+22.16%+16.84%
Expense Gross exp ratio0.35%1.32%
Risk 5 year sharpe ratio0.781.06
Net assets$2.6B$2.8B
Average market cap$4.5B$29.2B
Average P/E--21.1
Dividend / Share--0.32%


XLV Health Care Select Sector SPDR® Fund
FHLC Fidelity® MSCI Health Care Index ETF
RYH Guggenheim S&P 500® Equal Weight Health...


Top 5 Sectors
Portfolio weighting
Healthcare 100.00%
Business service 0.00%
Consumer goods 0.00%
Consumer service 0.00%
Energy 0.00%
Top 10 Holdings
Portfolio weighting
-- 3.98%
CLVS Clovis Oncology Inc3.76%
ACAD ACADIA Pharmaceuticals Inc2.74%
UTHR United Therapeutics Corp2.63%
EXAS Exact Sciences Corp2.60%
INCY Incyte Corp2.55%
VRTX Vertex Pharmaceuticals Inc2.37%
KITE Kite Pharma Inc2.35%
AMGN Amgen2.31%

Search for Jobs